Fluorine-19 MRI for visualization and quantification of cell migration in a diabetes model

Magnetic Resonance in Medicine

Volumn 58, Issue 4, 2007, Pages 725-734

  Srinivas, Mangala ^a   Morel, Penelope A ^b   Ernst, Lauren A ^a   Laidlaw, David H ^c   Ahrens, Eric T ^a  

^a CARNEGIE MELLON UNIVERSITY   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c Brown Univerity   (United States)

Author keywords

Cell tracking; Diabetes; Fluorocarbon; MRI; T cells

Indexed keywords

CELL CULTURE; CELL PROLIFERATION; FLUORESCENCE MICROSCOPY; FLUORINE; FLUOROCARBONS; MEDICAL PROBLEMS; T-CELLS;

CELL POPULATIONS; CELL TRACKING; CELL TRAFFICKING; CELLULAR THERAPEUTICS; COMPUTATIONAL ALGORITHM; LABELING PROCEDURES; NON-OBESE DIABETICS; PERFLUOROPOLYETHERS;

MAGNETIC RESONANCE IMAGING;

EXFLUOR; FLUORINE; NANOPARTICLE; PERFLUORO COMPOUND; PERFLUOROPOLYETHYLENE GLYCOL; POLOXAMER; POLYETHER DERIVATIVE; UNCLASSIFIED DRUG;

ALGORITHM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL LABELING; CELL PROLIFERATION; CELL TYPE; CELL VIABILITY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DISEASE MODEL; EMULSION; FLUORESCENCE MICROSCOPY; HISTOLOGY; INSULIN DEPENDENT DIABETES MELLITUS; LEUKOCYTE MIGRATION; LYMPHOCYTE COUNT; LYMPHOCYTE HOMING; MICROSCOPE; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PANCREAS; SPECTROMETER; T LYMPHOCYTE; TRANSGENIC MOUSE;

EID: 35048815466     PISSN: 07403194     EISSN: 15222594     Source Type: Journal    
DOI: 10.1002/mrm.21352     Document Type: Article

References (40)

1. Miyazaki A, Hanafusa T, Yamada K, Miyagawa J, Fujinokurihara H, Nakajima H, Nonaka K, Tarui S. Predominance of lymphocytes-T in pancreatic-islets and spleen of pre-diabetic non-obese diabetic (NOD) mice - a longitudinal-study. Clin Exp Immunol 1985;60:622-630.
2. Leiter EH, Prochazka M, Coleman DL. The nonobese diabetic (NOD) mouse. Am J Pathol 1987;128:380-383.
3. Yeh TC, Zhang W, Ildstad ST, Ho C. Intracellular labeling of T-cells with superparamagnetic contrast agents. Magn Reson Med 1993;30:617-625.
4. Lewin M, Carlesso N, Tung CH, Tang XW, Cory D, Scadden DT, Weissleder R. Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nat Biotechnol 2000;18:410-414.
5. Hoehn M, Kustermann E, Blunk J, Wiedermann D, Trapp T, Wecker S, Focking M, Arnold H, Hescheler J, Fleischmann BK, Schwindt W, Buhrle C. Monitoring of implanted stem cell migration in vivo: A highly resolved in vivo magnetic resonance imaging investigation of experimental stroke in rat. Proc Natl Acad Sci U S A 2002;99:16267-16272.
6. Ahrens ET, Feili-Hariri M, Xu H, Genove G, Morel PA. Receptor-mediated endocytosis of iron-oxide particles provides efficient labeling of dendritic cells for in vivo MR imaging. Magn Reson Med 2003;49:1006-1013.
7. Kircher MF, Allport JR, Graves EE, Love V, Josephson L, Lichtman AH, Weissleder R. In vivo high resolution three-dimensional imaging of antigen-specific cytotoxic T-lymphocyte trafficking to tumors. Cancer Res 2003;63:6838-6846.
8. Bulte JWM, Arbab AS, Douglas T, Frank JA. Preparation of magnetically labeled cells for cell tracking by magnetic resonance imaging. Method Enzymol 2004;386:275-299.
9. Modo M, Mellodew K, Cash D, Fraser SE, Meade TJ, Price J, Williams SCR. Mapping transplanted stem cell migration after a stroke: a serial, in vivo magnetic resonance imaging study. Neuroimage 2004;21:311-317.
10. Billotey C, Aspord C, Beuf O, Piaggio E, Gazeau F, Janier MF, Thivolet C. T-cell homing to the pancreas in autoimmune mouse models of diabetes: in vivo MR imaging. Radiology 2005;236:579-587.
11. Moore A, Grimm J, Han B, Santamaria P. Tracking the recruitment of diabetogenic CD8+ T-cells to the pancreas in real time. Diabetes 2004;53:1459-1466.
12. Anderson SA, Shukaliak-Quandt J, Jordan EK, Arbab AS, Martin R, McFarland H, Frank JA. Magnetic resonance imaging of labeled T-cells in a mouse model of multiple sclerosis. Ann Neurol 2004;55:654-659.
13. Evgenov NV, Medarova Z, Pratt J, Pantazopoulos P, Leyting S, Bonner-Weir S, Moore A. In vivo imaging of immune rejection in transplanted pancreatic islets. Diabetes 2006;55:2419-2428.
14. Evgenov NV, Medarova Z, Dai GP, Bonner-Weir S, Moore A. In vivo imaging of islet transplantation. Nat Med 2006;12:144-148.
15. Turvey SE, Swart E, Denis MC, Mahmood U, Benoist C, Weissleder R, Mathis D. Noninvasive imaging of pancreatic inflammation and its reversal in type 1 diabetes. J Clin Invest 2005;115:2454-2461.
16. Wu YL, Ye Q, Foley LM, Hitchens TK, Sato K, Williams JB, Ho C. In situ labeling of immune cells with iron oxide particles: An approach to detect organ rejection by cellular MRI. Proc Natl Acad Sci U S A 2006;103:1852-1857.
17. Shapiro EM, Sharer K, Skrtic S, Koretsky AP. In vivo detection of single cells by MRI. Magn Reson Med 2006;55:242-249.
18. Ahrens ET, Flores R, Xu H, Morel PA. In vivo imaging platform for tracking immunotherapeutic cells. Nat Biotechnol 2005;23:983-987.
19. You S, Chen C, Lee WH, Wu CH, Judkowski V, Pinilla C, Wilson DB, Liu CP. Detection and characterization of T cells specific for BDC2.5 T cell-stimulating peptides. J Immunol 2003;170:4011-4020.
20. Ablamunits V, Quintana F, Reshef T, Elias D, Cohen IR. Acceleration of autoimmune diabetes by cyclophosphamide is associated with an enhanced IFN-gamma secretion pathway. J Autoimmun 1999;13:383-392.
21. Gudbjartsson H, Patz S. The Rician distribution of noisy MRI data. Magn Reson Med 1995;34:910-914.
22. Cantor J, Haskins K. Effector function of diabetogenic CD4 Th1 T cell clones: a central role for TNF-alpha. J Immunol 2005;175:7738-7745.
23. Phillips JM HS, Parish NM, Fehervari Z, Haskins K, Cooke A. Nondepleting anti-CD4 has an immediate action on diabetogenic effector cells, halting their destruction of pancreatic beta cells. J Immunol 2000;165:1949-1955.
24. Meyer KL, Joseph PM, Mukherji B, Livolsi VA, Lin R. Measurement of vascular volume in experimental rat tumors by 19F magnetic resonance imaging. Invest Radiol 1993;28:710-719.
25. Fishman JE, Joseph PM, Floyd TF, Mukherji B, Sloviter HA. Oxygen-sensitive 19F NMR imaging of the vascular system in vivo. Magn Reson Imaging 1987;5:279-285.
26. Eidelberg D, Johnson G, Barnes D, Tofts PS, Delpy D, Plummer D, McDonald WI. 19F NMR imaging of blood oxygenation in the brain. Magn Reson Med 1988;6:344-352.
27. McGoron AJ, Pratt R, Zhang J, Shiferaw Y, Thomas S, Millard R. Perfluorocarbon distribution to liver, lung and spleen of emulsions of perfluorotributylamine (FTBA) in pigs and rats and perfluorooctyl bromide (PFOB) in rats and dogs by 19F NMR spectroscopy. Artif Cells Blood Sub 1994;22:1243-1250.
28. Dardzinski BJ, Sotak CH. Rapid tissue oxygen tension mapping using 19F inversion-recovery echo-planar imaging of perfluoro-15-crown-5-ether. Magn Reson Med 1994;32:88-97.
29. Noth U, Morrissey SP, Deichmann R, Adolf H, Schwarzbauer C, Lutz J, Haase A. In vivo measurement of partial oxygen pressure in large vessels and in the reticuloendothelial system using fast 19F-MRI. Magn Reson Med 1995;34:738-745.
30. Lutz J, Noth U, Morrissey SP, Adolf H, Deichmann R, Haase A. Measurement of oxygen tensions in the abdominal cavity and in the skeletal muscle using 19F-MRI of neat PFC droplets. Adv Exp Med Biol 1997;428:569-572.
31. Sotak CH, Hees PS, Huang HN, Hung MH, Krespan CG, Raynolds S. A new perfluorocarbon for use in fluorine-19 magnetic resonance imaging and spectroscopy. Magn Reson Med 1993;29:188-195.
32. Xia MN, Kodibagkar V, Liu HL, Mason RP. Tumour oxygen dynamics measured simultaneously by near-infrared spectroscopy and F-19 magnetic resonance imaging in rats. Phys Med Biol 2006;51:45-60.
33. Morawski AM, Winter PM, Yu X, Fuhrhop RW, Scott MJ, Hockett F, Robertson JD, Gaffney PJ, Lanza GM, Wickline SA. Quantitative "magnetic resonance immunohistochemistry" with ligand-targeted F-19 nanoparticles. Magn Reson Med 2004;52:1255-1262.
34. Lanza GM, Winter PM, Neubauer AM, Caruthers SD, Hockett FD, Wickline SA. 1H/19F magnetic resonance molecular imaging with perfluorocarbon nanoparticles. In: Ahrens ET, editor. In vivo cellular and molecular imaging. Vol. 70. Current topics in developmental biology. San Diego: Elsevier; 2005. p 58-78.
35. Pelchen-Matthews A, Parsons IJ, Marsh M. Phorbol ester-induced downregulation of CD4 is a multistep process involving dissociation from p56lck, increased association with clathrin-coated pits, and altered endosomal sorting. J Exp Med 1993;178:1209-1222.
36. Phillips JM, Haskins K, Cooke A. MAdCAM-1 is needed for diabetes development mediated by the T cell clone, BDC-2.5. Immunology 2005;116:525-531.
37. Pakala SV, Kurrer MO, Katz JD. T helper 2 (Th2) T cells induce acute pancreatitis and diabetes in immune-compromised nonobese diabetic (NOD) mice. J Exp Med 1997;186:299-306.
38. Fabien N, Bergerot I, Maguer-Satta V, Orgiazzi J, Thivolet C. Pancreatic lymph nodes are early targets of T cells during adoptive transfer of diabetes in NOD mice. J Autoimmun 1995;8:323-334.
39. Miller MJ, Safrina O, Parker I, Cahalan MD. Imaging the single cell dynamics of CD4+ T cell activation by dendritic cells in lymph nodes. J Exp Med 2004;200:847-856.
40. Ribeiro RM, Mohri H, Ho DD, Perelson AS. In vivo dynamics of T cell activation, proliferation, and death in HIV-1 infection: why are CD4+ but not CD8+ T cells depleted? Proc Natl Acad Sci U S A 2002;99:15572-15577.